1. Experimental study on the inhibitory effect of sodium cantharidinate on human hepatoma HepG2 cells
- Author
-
Ming Hu, Shi-Qi Wen, and Quan Chen
- Subjects
Carcinoma, Hepatocellular ,VEGF receptors ,Sodium ,Short Communications ,chemistry.chemical_element ,Antineoplastic Agents ,Apoptosis ,Biology ,chemistry.chemical_compound ,Drug Discovery ,Animals ,Humans ,MTT assay ,Inhibitory effect ,Cell Proliferation ,Cantharidin ,Dose-Response Relationship, Drug ,Cell growth ,Liver Neoplasms ,sodium cantharidinate ,human hepatoma HepG2 ,Hep G2 Cells ,Molecular biology ,digestive system diseases ,Coleoptera ,Complementary and alternative medicine ,chemistry ,Biochemistry ,Hepg2 cells ,biology.protein - Abstract
Backgroud: Cantharidin, and its derivatives can not only inhibit the proliferation of tumor cells, but can also induce tumor cell apoptosis. It shows cantharidin exhibits a wide range of reactivity in anticancer. The objective of this paper was to study the inhibitory effect of sodium cantharidinate on human hepatoma HepG2 cells.Materials and Methods: MTT assay was used to detect the proliferation of HepG2 cells, and immunohisto-chemical method was used to detect the change in VEGF, protein level, and to determine the inhibitory effect of sodium cantharidinate on human hepatoma HepG2 cells.Results: As results, sodium cantharidinate significantly inhibited the growth of HepG2 cells in a time-and dose-dependent manner.Conclusion: We conclude that sodium cantharidinate has an inhibitory effect on human hepatoma HepG2 cells.Key words: sodium cantharidinate; human hepatoma HepG2; MTT assay
- Published
- 2013